Literature DB >> 17690891

Protective role of erythropoietin during testicular torsion of the rats.

Nuray Yazihan1, Haluk Ataoglu, Naim Koku, Esra Erdemli, Ayse Kose Sargin.   

Abstract

Testicular torsion is an important clinical urgency. Similar mechanisms occurred after detorsion of the affected testis as in the ischemia reperfusion (I/R) damage. This study was designed to investigate the effects of erythropoietin (EPO) treatment after unilateral testicular torsion. Fifty male Sprague-Dawley rats were divided into five groups. Group 1 underwent a sham operation of the right testis under general anesthesia. Group 2 was same as sham, and EPO (3,000 IU/kg) infused i.p., group 3 underwent a similar operation but the right testis was rotated 720 degrees clockwise for 1 h, maintained by fixing the testis to the scrotum, and saline infused during the procedure. Group 4 underwent similar torsion but EPO was infused half an hour before the detorsion procedure, and in group 5, EPO was infused after detorsion procedure. Four hours after detorsion, ipsilateral and contralateral testes were taken out for evaluation. Treatment with EPO improved testicular structures in the ipsilateral testis but improvement was less in the contralateral testis histologically, but EPO treatment decreased germ cell apoptosis in both testes following testicular IR. TNF-alpha, IL-1beta, IL-6 and nitrite levels decreased after EPO treatment especially in the ipsilateral testis. We conclude that testicular I/R causes an increase in germ cell apoptosis both in the ipsilateral and contralateral testes. Erythropoietin has antiapoptotic and anti-inflammatory effects following testicular torsion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17690891     DOI: 10.1007/s00345-007-0200-9

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  22 in total

1.  Recombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the rat.

Authors:  Bruno Sepodes; Rui Maio; Rui Pinto; Edward Sharples; Pedro Oliveira; Michelle McDonald; Muhammad Yaqoob; Christoph Thiemermann; Helder Mota-Filipe
Journal:  Transpl Int       Date:  2006-11       Impact factor: 3.782

2.  Interleukin-1beta regulates nitric oxide production and gamma-glutamyl transpeptidase activity in sertoli cells.

Authors:  S B Meroni; A M Suburo; S B Cigorraga
Journal:  J Androl       Date:  2000 Nov-Dec

3.  Bacterial lipopolysaccharide-induced oxidative stress in the impairment of steroidogenesis and spermatogenesis in rats.

Authors:  Mallikarjuna M Reddy; Suraneni V K Mahipal; Jagu Subhashini; Madhava C Reddy; Karnati R Roy; Gorla V Reddy; Pingili R K Reddy; Pallu Reddanna
Journal:  Reprod Toxicol       Date:  2006-04-27       Impact factor: 3.143

4.  Interleukin-1beta signals through a c-Jun N-terminal kinase-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells.

Authors:  Tomomoto Ishikawa; Patricia L Morris
Journal:  Endocrinology       Date:  2006-08-03       Impact factor: 4.736

5.  Ipsilateral and contralateral testicular biochemical acute changes after unilateral testicular torsion and detorsion.

Authors:  F M Akgür; K Kilinç; F C Tanyel; N Büyükpamukçu; A Hiçsönmez
Journal:  Urology       Date:  1994-09       Impact factor: 2.649

6.  Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells.

Authors:  C Zoja; J M Wang; S Bettoni; M Sironi; D Renzi; F Chiaffarino; H E Abboud; J Van Damme; A Mantovani; G Remuzzi
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

7.  Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure.

Authors:  D W Johnson; B Pat; D A Vesey; Z Guan; Z Endre; G C Gobe
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

8.  Recombinant human erythropoietin (rhEPO) preconditioning on nuclear factor-kappa B (NF-kB) activation & proinflammatory cytokines induced by myocardial ischaemia-reperfusion.

Authors:  Xiaoming Liu; Jinchun Shen; Yi Jin; Manlin Duan; Jianguo Xu
Journal:  Indian J Med Res       Date:  2006-09       Impact factor: 2.375

9.  Involvement of p38 mitogen-activated protein kinase and inducible nitric oxide synthase in apoptotic signaling of murine and human male germ cells after hormone deprivation.

Authors:  Yanira Vera; Krista Erkkilä; Christina Wang; Concepcion Nunez; Sauli Kyttänen; Yanhe Lue; Leo Dunkel; Ronald S Swerdloff; Amiya P Sinha Hikim
Journal:  Mol Endocrinol       Date:  2006-02-09

10.  Testicular nitric oxide and thiobarbituric acid reactive substances levels in obstructive azoospermia: a possible role in pathophysiology of infertility.

Authors:  M Murad Başar; Uçler Kisa; Devrim Tuğlu; Erdal Yilmaz; Halil Başar; Osman Cağlayan; Ertan Batislam
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

View more
  12 in total

1.  Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergic antiinflammatory pathway.

Authors:  Letteria Minutoli; Alessandra Bitto; Francesco Squadrito; Natasha Irrera; Mariagrazia Rinaldi; Piero Antonio Nicotina; Salvatore Arena; Carlo Magno; Herbert Marini; Luca Spaccapelo; Alessandra Ottani; Daniela Giuliani; Carmelo Romeo; Salvatore Guarini; Pietro Antonuccio; Domenica Altavilla
Journal:  Endocrinology       Date:  2011-08-09       Impact factor: 4.736

2.  Testicular Torsion and Spermatogenesis.

Authors:  Omar Al Hussein Alawamlh; Ryan Flannigan; Russell Hayden; Marc Goldstein; Philip S Li; Richard K Lee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Comparison of erythropoietin and sildenafil protective role against ischemia/reperfusion injury of the testis in adult rats.

Authors:  Nick Zavras; Ioannis D Kostakis; Stratigoula Sakellariou; Christos Damaskos; Evangelos Roupakas; Eleni Tsagkari; Eleftherios Spartalis; Konstantinos Velaoras; Ismene A Dontas; Theodore Karatzas
Journal:  Int Urol Nephrol       Date:  2013-10-05       Impact factor: 2.370

Review 4.  Mechanisms of testicular torsion and potential protective agents.

Authors:  Ersagun Karaguzel; Mustafa Kadihasanoglu; Omer Kutlu
Journal:  Nat Rev Urol       Date:  2014-06-17       Impact factor: 14.432

5.  Effect of korean red ginseng on testicular tissue injury after torsion and detorsion.

Authors:  Young-Ho Kim; Gun-Hwa Kim; Ju-Hyun Shin; Kang-Sup Kim; Jae-Sung Lim
Journal:  Korean J Urol       Date:  2010-11-17

6.  Protective effect of trapidil on long-term histologic damage in a rat model of testicular ischemia-reperfusion injury.

Authors:  Murat Bozlu; Deniz Acar; Selahittin Cayan; Savas Aktas; Ahmet Tunckiran
Journal:  World J Urol       Date:  2008-09-02       Impact factor: 4.226

7.  The protective effect of erythropoietin infusion on testicular torsion/detorsion: an experimental study.

Authors:  Burhan Köseoğlu; Engin Yilmaz; Kadir Ceylan; Ersan Uzun; Irfan Bayram; Fatih Hizli
Journal:  Int Urol Nephrol       Date:  2008-07-15       Impact factor: 2.370

8.  Protective effect of sildenafil citrate on contralateral testis injury after unilateral testicular torsion/detorsion.

Authors:  Hamit Yíldíz; Ali Said Durmus; Halil Simşek; Mine Yaman
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Erythropoietin and sildenafil protect against ischemia/reperfusion injury following testicular torsion in adult rats.

Authors:  Ioannis D Kostakis; Nick Zavras; Christos Damaskos; Stratigoula Sakellariou; Penelope Korkolopoulou; Evangelos P Misiakos; Petros Tsaparas; George Vaos; Theodoros Karatzas
Journal:  Exp Ther Med       Date:  2017-05-08       Impact factor: 2.447

10.  The effect of erythropoietin on ischemia/reperfusion injury after testicular torsion/detorsion: a randomized experimental study.

Authors:  Fahimeh Kazemi Rashed; Babollah Ghasemi; Hamid Deldade Mogaddam; Mehran Mesgari
Journal:  ISRN Urol       Date:  2013-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.